Royalty Pharma plc Class A Ordinary Shares — Quarterly Financial Statements (NASDAQ:RPRX) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Market Capitalization 19.8611 B
Employee 100
Founded 1996
CEO N/A
Website www.royaltypharma.com
Headquarter United Kingdom
FIGI N/A
Industry Technology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

19.86 B Market capitalization

Price to earnings ratio

21.71

Price to sales ratio

9.17

Dividends per share

0.88

Dividend yield %

2.28

Haberler

TD Cowen, Royalty Pharma için hisse hedefini büyüme ile 50 dolara yükseltti

TD Cowen raises Royalty Pharma stock price target to $50 on growth

Royalty Pharma hissesi 46,14 dolarda 52 haftalık zirve yaptı

Royalty Pharma stock hits 52-week high at 46.14 USD

Royalty Pharma Stock: 2025 Financial Performance And Strategic Outlook (NASDAQ:RPRX)

The Week That Was, The Week Ahead: Macro and Markets, Feb. 15 - TipRanks.com

Dividend Champion, Contender, And Challenger Highlights: Week Of February 15

BofA Securities, Royalty Pharma hissesi için Al tavsiyesini 54 dolar hedefle yineliyor

Royalty Pharma plc (RPRX) Q4 2025 Earnings Call Transcript

Royalty Pharma hisseleri 44,94 dolar ile 52 haftalık zirveye ulaştı

Royalty Pharma stock hits 52-week high at 44.94 USD

Royalty Pharma Q4 2025 slides: double-digit growth amid synthetic royalty expansion